CSO Speaks at the World Anti-Microbial Congress
Our CSO, Mariana Castanheira, will be speaking at the World Anti-Microbial Congress on October 8 and 9. On October 8, she will discuss how the genetic characterization of AMR isolates strengthens clinical trial data. On October 9, she will share how breakpoints impact the commercialization and market access for new antimicrobials alongside Michael Dudley, the President, CEO, and Co-Founder of QPex Biopharma. The panel will be moderated by Kevin Krause, the Vice President of Clinical Sciences and Operations at AN2 Therapeutics.
